Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Cell Structure and Function|July 8, 2000
The pleiotropic effects of fibroblast growth factor receptors in mammalian developmentI McIntosh, G A Bellus, E W JabThe British Journal of Dermatology|November 28, 2002
Genes, growth factors and acanthosis nigricansD Torley, G A Bellus, C S MunroThe Journal of Pediatrics|May 15, 1998
Long-term use of high-dose benzoate and dextromethorphan for the treatment of nonketotic hyperglycinemiaA Hamosh, J F Maher, G A Bellus, et al.Nature Genetics|October 1, 1996
Identical mutations in three different fibroblast growth factor receptor genes in autosomal dominant craniosynostosis syndromesG A Bellus, K Gaudenz, E H Zackai, et al.Nature Genetics|July 1, 1995
A recurrent mutation in the tyrosine kinase domain of fibroblast growth factor receptor 3 causes hypochondroplasiaG A Bellus, I McIntosh, E A Smith, et al.American Journal of Human Genetics|February 1, 1995
Achondroplasia is defined by recurrent G380R mutations of FGFR3G A Bellus, T W Hefferon, R I Ortiz de Luna, et al.American Journal of Human Genetics|August 27, 1998
Mutations in fibroblast growth-factor receptor 3 in sporadic cases of achondroplasia occur exclusively on the paternally derived chromosomeD J Wilkin, J K Szabo, R Cameron, et al.Human Molecular Genetics|May 1, 1994
Localization of the achondroplasia gene to the distal 2.5 Mb of human chromosome 4pC A Francomano, R I Ortiz de Luna, T W Hefferon, et al.American Journal of Human Genetics|October 31, 2000
Distinct missense mutations of the FGFR3 lys650 codon modulate receptor kinase activation and the severity of the skeletal dysplasia phenotypeG A Bellus, E B Spector, P W Speiser, et al.American Journal of Medical Genetics|June 22, 1999
Severe achondroplasia with developmental delay and acanthosis nigricans (SADDAN): phenotypic analysis of a new skeletal dysplasia caused by a Lys650Met mutation in fibroblast growth factor receptor 3G A Bellus, M J Bamshad, K A Przylepa, et al.Pageof 2